AstraZeneca pays SEC US$5.5 million after 10-year FCPA investigation
UK-based pharmaceutical company AstraZeneca will pay US$5.5 million to resolve charges it violated the Foreign Corrupt Practices Act, while the Justice Department has closed its investigation into the matter.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10